Literature DB >> 18801929

Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.

Jaetaek Kim1, Adam R Wende, Sandra Sena, Heather A Theobald, Jamie Soto, Crystal Sloan, Benjamin E Wayment, Sheldon E Litwin, Martin Holzenberger, Derek LeRoith, E Dale Abel.   

Abstract

The receptors for IGF-I (IGF-IR) and insulin (IR) have been implicated in physiological cardiac growth, but it is unknown whether IGF-IR or IR signaling are critically required. We generated mice with cardiomyocyte-specific knockout of IGF-IR (CIGF1RKO) and compared them with cardiomyocyte-specific insulin receptor knockout (CIRKO) mice in response to 5 wk exercise swim training. Cardiac development was normal in CIGF1RKO mice, but the hypertrophic response to exercise was prevented. In contrast, despite reduced baseline heart size, the hypertrophic response of CIRKO hearts to exercise was preserved. Exercise increased IGF-IR content in control and CIRKO hearts. Akt phosphorylation increased in exercise-trained control and CIRKO hearts and, surprisingly, in CIGF1RKO hearts as well. In exercise-trained control and CIRKO mice, expression of peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) and glycogen content were both increased but were unchanged in trained CIGF1RKO mice. Activation of AMP-activated protein kinase (AMPK) and its downstream target eukaryotic elongation factor-2 was increased in exercise-trained CIGF1RKO but not in CIRKO or control hearts. In cultured neonatal rat cardiomyocytes, activation of AMPK with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) prevented IGF-I/insulin-induced cardiomyocyte hypertrophy. These studies identify an essential role for IGF-IR in mediating physiological cardiomyocyte hypertrophy. IGF-IR deficiency promotes energetic stress in response to exercise, thereby activating AMPK, which leads to phosphorylation of eukaryotic elongation factor-2. These signaling events antagonize Akt signaling, which although necessary for mediating physiological cardiac hypertrophy, is insufficient to promote cardiac hypertrophy in the absence of myocardial IGF-I signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801929      PMCID: PMC2582541          DOI: 10.1210/me.2008-0265

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  42 in total

1.  Akt1 is required for physiological cardiac growth.

Authors:  Brian DeBosch; Iya Treskov; Traian S Lupu; Carla Weinheimer; Attila Kovacs; Michael Courtois; Anthony J Muslin
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart.

Authors:  Daisuke Fujioka; Ken-ichi Kawabata; Yukio Saito; Tsuyoshi Kobayashi; Takamitsu Nakamura; Yasushi Kodama; Hajime Takano; Jyun-ei Obata; Yoshinobu Kitta; Ken Umetani; Kiyotaka Kugiyama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01-13       Impact factor: 4.733

Review 3.  Regulation of cardiac hypertrophy by intracellular signalling pathways.

Authors:  Joerg Heineke; Jeffery D Molkentin
Journal:  Nat Rev Mol Cell Biol       Date:  2006-08       Impact factor: 94.444

Review 4.  Regulating insulin signaling and beta-cell function through IRS proteins.

Authors:  Morris F White
Journal:  Can J Physiol Pharmacol       Date:  2006-07       Impact factor: 2.273

Review 5.  AMPK alterations in cardiac physiology and pathology: enemy or ally?

Authors:  Jason R B Dyck; Gary D Lopaschuk
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

6.  c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor.

Authors:  Axelle Cadoret; Christèle Desbois-Mouthon; Dominique Wendum; Patricia Leneuve; Christine Perret; François Tronche; Chantal Housset; Martin Holzenberger
Journal:  Int J Cancer       Date:  2005-04-20       Impact factor: 7.396

7.  Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.

Authors:  Ji Luo; Julie R McMullen; Cassandra L Sobkiw; Li Zhang; Adam L Dorfman; Megan C Sherwood; M Nicole Logsdon; James W Horner; Ronald A DePinho; Seigo Izumo; Lewis C Cantley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

8.  Cardiac adaptations to chronic exercise in mice.

Authors:  M L Kaplan; Y Cheslow; K Vikstrom; A Malhotra; D L Geenen; A Nakouzi; L A Leinwand; P M Buttrick
Journal:  Am J Physiol       Date:  1994-09

9.  Calcineurin and calcium/calmodulin-dependent protein kinase activate distinct metabolic gene regulatory programs in cardiac muscle.

Authors:  Paul J Schaeffer; Adam R Wende; Carolyn J Magee; Joel R Neilson; Teresa C Leone; Feng Chen; Daniel P Kelly
Journal:  J Biol Chem       Date:  2004-07-19       Impact factor: 5.157

10.  Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout.

Authors:  Christèle Desbois-Mouthon; Dominique Wendum; Axelle Cadoret; Colette Rey; Patricia Leneuve; Annick Blaise; Chantal Housset; François Tronche; Yves Le Bouc; Martin Holzenberger
Journal:  FASEB J       Date:  2006-02-16       Impact factor: 5.191

View more
  80 in total

1.  Exercise training improves vascular mitochondrial function.

Authors:  Song-Young Park; Matthew J Rossman; Jayson R Gifford; Leena P Bharath; Johann Bauersachs; Russell S Richardson; E Dale Abel; J David Symons; Christian Riehle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

Review 2.  Cardiovascular Adaptations Induced by Resistance Training in Animal Models.

Authors:  S F S Melo; N D da Silva Júnior; V G Barauna; E M Oliveira
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

Review 3.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

4.  Insulin receptor substrate signaling suppresses neonatal autophagy in the heart.

Authors:  Christian Riehle; Adam R Wende; Sandra Sena; Karla Maria Pires; Renata Oliveira Pereira; Yi Zhu; Heiko Bugger; Deborah Frank; Jack Bevins; Dong Chen; Cynthia N Perry; Xiaocheng C Dong; Steven Valdez; Monika Rech; Xiaoming Sheng; Bart C Weimer; Roberta A Gottlieb; Morris F White; E Dale Abel
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

5.  Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome.

Authors:  Olesya Ilkun; Nicole Wilde; Joseph Tuinei; Karla M P Pires; Yi Zhu; Heiko Bugger; Jamie Soto; Benjamin Wayment; Curtis Olsen; Sheldon E Litwin; E Dale Abel
Journal:  J Mol Cell Cardiol       Date:  2015-05-22       Impact factor: 5.000

Review 6.  Cardiac adaptation to exercise training in health and disease.

Authors:  Dae Yun Seo; Hyo-Bum Kwak; Amy Hyein Kim; Se Hwan Park; Jun Won Heo; Hyoung Kyu Kim; Jeong Rim Ko; Sam Jun Lee; Hyun Seok Bang; Jun Woo Sim; Min Kim; Jin Han
Journal:  Pflugers Arch       Date:  2019-04-23       Impact factor: 3.657

Review 7.  The Role of MicroRNAs in the Cardiac Response to Exercise.

Authors:  Xiaojun Liu; Colin Platt; Anthony Rosenzweig
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 8.  Molecular basis of physiological heart growth: fundamental concepts and new players.

Authors:  Marjorie Maillet; Jop H van Berlo; Jeffery D Molkentin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01       Impact factor: 94.444

9.  IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro.

Authors:  Anastasia Stavropoulou; Antonios Halapas; Antigone Sourla; Anastassios Philippou; Efstathia Papageorgiou; Apostolos Papalois; Michael Koutsilieris
Journal:  Mol Med       Date:  2009-03-06       Impact factor: 6.354

Review 10.  Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?

Authors:  Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.